Biopharmaceutical company focused on developing innovative medicines, including crisaborole, a non-steroidal topical treatment for mild-to-moderate eczema (atopic dermatitis)
Biopharmaceutical company focused on developing innovative medicines, including crisaborole, a non-steroidal topical treatment for mild-to-moderate eczema (atopic dermatitis). Pfizer agreed to acquire Anacor in 2016.